These medications work through different but related mechanismssemaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
The animal literature is unusually consistent, though: nearly every published in vivo study used 5 mg/kg per injection, given three times on alternate days (days 1, 3, and 5, or days 14, 16, and 18 in the pulmonary fibrosis model), with effects tracked over the following three to four weeks
GLP-1 is a vital hormone involved in overall wellness
Tell your healthcare provider if you have changes in vision during treatment with Wegovy Increased heart rate
Why 90% of clinical drug development fails and how to improve it